| 1. | | Recruiting | A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes |
| 2. | | Recruiting | Tipifarnib versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Conditions: Myeloid Leukemia; Acute Disease |
| 3. | | Recruiting | Fludarabine, Low-Dose Total-Body Irradiation, Donor Stem Cell Transplantation, and Immunosuppression Therapy in Treating Patients Who Have Fanconi’s Anemia
Conditions: Fanconi's Anemia; adult acute myeloid leukemia; childhood acute myeloid leukemia; Graft Versus Host Disease; Myelodysplastic Syndromes |
| 4. | | Recruiting | Darbepoetin alfa in Treating Anemic Patients With Myelodysplastic Syndromes
Conditions: Anemia; Fatigue; Myelodysplastic Syndromes |
| 5. | | Recruiting | PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ... |
| 6. | | Recruiting | Anti-Thymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia |
| 7. | | Recruiting | Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 8. | | Recruiting | Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes |
| 9. | | Recruiting | Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 10. | | Recruiting | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; ... |
| 11. | | Recruiting | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 12. | | Recruiting | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
| 13. | | Recruiting | Cilengitide in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 14. | | Recruiting | Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 15. | | Not yet recruiting | FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 16. | | Recruiting | Thymoglobulin to Prevent Acute Graft vs. Host (GvHD) in Patients with Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant
Conditions: Acute myelogenous leukemia (AML); Acute lymphocytic leukemia (ALL); Graft vs. Host Disease (GvHD) |
| 17. | | Recruiting | PTK 787 and Gleevec in Patients with AML, AMM, and CML-BP
Conditions: Acute Myelogenous Leukemia; Agnogenic Myeloid Metaplasia; Chronic Myelogenous Leukemia |
| 18. | | Recruiting | Clofarabine alone versus Clofarabine in Combination with Low-Dose Cytarabine (ara-C) in Previously Untreated Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome |
| 19. | | Recruiting | CC-5013 in Myelofibrosis
Condition: Myelofibrosis |
| 20. | | Recruiting | Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 21. | | Recruiting | Study of AP23573 in Patients with Relapsed or Refractory Hematologic Malignancies
Conditions: Hematologic Malignancies; Leukemia; Myelodysplastic Syndromes; Myeloid Metaplasia; Lymphoma |
| 22. | | Recruiting | Induction Therapy Using Cytarabine, Daunorubicin, and, Optionally, Gemtuzumab Ozogamicin Followed By Consolidation Therapy With High-Dose Cytarabine and Postconsolidation Therapy With Gemtuzumab Ozogamicin Compared With No Additional Therapy in Patients With Untreated De Novo Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 23. | | Recruiting | Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 24. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 25. | | Recruiting | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Conditions: Fanconi's Anemia; Cancer |
| 26. | | Recruiting | VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ... |
| 27. | | Recruiting | Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; relapsing chronic myelogenous leukemia; ... |
| 28. | | Recruiting | RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
Conditions: Leukemia; Mantle Cell Lymphoma; Myelofibrosis |
| 29. | | Recruiting | OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 30. | | Recruiting | T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
| 31. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ... |
| 32. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 33. | | Recruiting | CC-5013 in Treating Patients With Transfusion-Dependent Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
Conditions: Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; ... |
| 34. | | Recruiting | Sirolimus in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: chronic myeloproliferative disorders; Graft Versus Host Disease; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 35. | | Recruiting | Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia
Conditions: recurrent childhood acute lymphoblastic leukemia; childhood chronic myelogenous leukemia; recurrent childhood acute myeloid leukemia; ... |
| 36. | | Recruiting | 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia |
| 37. | | Recruiting | Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
Conditions: adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 38. | | Recruiting | Filgrastim-Mobilized Peripheral Stem Cell Transplantation Compared With Bone Marrow Transplantation From Unrelated Donors in Treating Patients With Hematologic Malignancies
Conditions: acute leukemia; chronic leukemia; chronic myeloproliferative disorders; myelodysplastic and myeloproliferative disease |
| 39. | | Recruiting | Daclizumab Compared With Antithymocyte Globulin in Treating Cytopenia in Patients With Myelodysplastic Syndromes
Conditions: Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; previously treated myelodysplastic syndromes; ... |
| 40. | | Recruiting | Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia; Myelodysplastic Syndromes |
| 41. | | Recruiting | Sirolimus to Prevent GVHD after Stem Cell Transplant for Blood Cancers
Conditions: Hematologic Neoplasms; Neural Tube Defects; Myeloproliferative Disorders |
| 42. | | Recruiting | Infliximab in Treating Patients With Myelodysplastic Syndrome
Conditions: refractory anemia with excess blasts; refractory anemia with ringed sideroblasts; Refractory Anemia; de novo myelodysplastic syndromes; ... |
| 43. | | Recruiting | Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
Conditions: Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 44. | | Recruiting | A Survival Study in Patients with High Risk Myelodysplastic Syndromes Comparing Azacitidine versus Conventional Care
Condition: Myelodysplastic Syndromes |
| 45. | | Recruiting | GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Conditions: recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ... |
| 46. | | Recruiting | VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 47. | | Recruiting | Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
Conditions: childhood acute monocytic leukemia; childhood acute myeloid leukemia |
| 48. | | Recruiting | Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 49. | | Recruiting | Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorder or Myelodysplastic Syndrome
Conditions: Polycythemia Vera; Essential Thrombocythemia; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ... |
| 50. | | Recruiting | Genetic Analysis of Gray Platelet Syndrome
Conditions: Genetic Linkage; Myelofibrosis |
